Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis Laura J. SavageMiriam WittmannPhilip S. Helliwell Review Open access 17 March 2015 Pages: 1 - 16
Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab Andra F. NegoescuAndrew J. K. Östör Review Open access 25 December 2014 Pages: 17 - 31
Epigenetic Aspects of Systemic Lupus Erythematosus Manfred RelleBernd FoehrAndreas Schwarting Review Open access 16 June 2015 Pages: 33 - 46
The Tissue-Selective Estrogen Complex: A Review of Current Evidence Rinu PazhekattuArthur N. LauJonathan D. Adachi Review Open access 20 May 2015 Pages: 47 - 58
Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another Biologic Stephen S. JohnstonDonna McMorrowSarika Ogale Original Research Open access 23 December 2014 Pages: 59 - 71
Assessing Methotrexate Adherence in Rheumatoid Arthritis: A Cross-Sectional Survey Dana B. DiBenedettiXiaolei ZhouJennie H. Best Original Research Open access 13 May 2015 Pages: 73 - 84
Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population Dimitrios A. PappasGeorge W. ReedJoel M. Kremer Original Research Open access 27 January 2015 Pages: 85 - 96
Erratum to: Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis Philip J. Mease Erratum Open access 24 February 2015 Pages: 97 - 97
